Community Pharmacy MMR Enhanced Service

Location

London:

Description

NHS England (London Region) direct award C under PSR23 for Community Pharmacy MMR Enhanced Service

Total Quantity or Scope

The notice relates to Community Pharmacy MMR Enhanced health care services. This notice is an intention to award a contract to the existing provider following direct award process C. The lifetime Value of the contract is activity based determined by the £10.06 single fee per administration. The contract term will be 1 year. The contract will start on 01/04/2025 and end 31/03/2026

Award Detail

Award Criteria

CPV Codes

• 85100000 - Health services

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 01/05/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Dawn Hollis Head of ANNB Screening, Immunisations, CHIS, ICARS, Digital Transformation Decision made: 06/03/2025 5 key criteria selected: (1) Quality and Innovation: 20% (2) Value: 20% (3) Integration, collaboration and service sustainability: 20% (4) Improving access, reducing health inequalities and facilitating choice: 20% (5) Social value: 20% Providers assessed on a Pass/Fail basis against 3 basic selection criteria. All Scored and Pass/Fail criteria are met. No conflicts of interest declared.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **